Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the
Vitamin D Testing Sales Market
Request Now !
Vitamin D plays a vital role to control the calcium and phosphate levels in the body. It also helps maintain the cell cycle, fetus development, prevention of neuromuscular disorders, and bone disorders. The deficiency of vitamin D leads to rickets, osteoporosis, cardiovascular diseases, cognitive disorders, cancer, autoimmune diseases, and asthma.
Increase in prevalence of vitamin D deficiency due to the lack of exposure to sunlight, low intake of vitamin D diet, poor absorption of food, liver or kidney diseases, and certain drugs such as phenytoin, rifampin, and phenobarbital majorly drives the market growth. In addition, rise in the prevalence of orthopedic diseases, cognitive disorders, cancer, and asthma fuels the growth of the market.
Furthermore, increase in investment and awareness by government and private organizations and cost-efficient vitamin D deficiency test is anticipated to create new opportunities during the forecast period. However, decline rate of reimbursement and stringent government regulations associated with the sales of vitamin D deficiency is anticipated to hinder the growth of the market.
The market is segmented on the basis of vitamin type, application, end user, and geography. Based on the vitamin type, it is bifurcated into vitamin D3 and D2. Based on the application, it is classified into functional food & beverages, pharmaceuticals, animal feed & pet food, and personal care.
Based on end users, the vitamin D testing market is divided into pediatrics, adults, geriatrics, and pregnant women. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
- The study provides an in-depth analysis of the global vitamin D testing sales market, with current trends and future estimations to elucidate the investment pockets.
- Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
- The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis of different segments facilitates to understand various products of the market.
- Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.
Vitamin D Testing Sales Market Key Segments:
By Vitamin Type
- Functional Food & Beverages
- Animal Feed & Pet Food
- Personal Care
By End User
- Pregnant Women
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia-Pacific
- Latin America
- Middle East
List of players profiled in the report
- BioMrieux Inc
- Abbott Laboratories Inc.
- Siemens Healthineers
- F. Hoffmann-La Roche
- DiaSorin S.p.A.
- Hologic, Inc.
- Biokit S.A.
- The Vitamin D Company
- Tosoh Bioscience
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
CHAPTER 4 VITAMIN D TESTING SALES MARKET, BY VITAMIN TYPE
4.1.1. Market size and forecast
4.2. VITAMIN D2
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. VITAMIN D3
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 VITAMIN D TESTING SALES MARKET, BY APPLICATION
5.1.1. Market size and forecast
5.2. FUNCTIONAL FOOD & BEVERAGES
5.2.1. Market size and forecast
5.3.1. Market size and forecast
5.4. ANIMAL FEED & PET FOOD
5.4.1. Market size and forecast
5.5. PERSONAL CARE
5.5.1. Market size and forecast
CHAPTER 6 VITAMIN D TESTING SALES MARKET, BY END USER
6.1.1. Market size and forecast
6.2.1. Market size and forecast
6.3.1. Market size and forecast
6.4.1. Market size and forecast
6.5. PREGNANT WOMEN
6.5.1. Market size and forecast
CHAPTER 7 VITAMIN D TESTING SALES MARKET, BY GEOGRAPHY
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
22.214.171.124. U.S. market size and forecast
126.96.36.199. Canada market size and forecast
188.8.131.52. Mexico market size and forecast
7.2.4. North America Vitamin D Testing Sales Market by Vitamin Type
7.2.5. North America Vitamin D Testing Sales Market by End User
7.2.6. North America Vitamin D Testing Sales Market by Application
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
184.108.40.206. Germany market size and forecast
220.127.116.11. France market size and forecast
18.104.22.168. UK market size and forecast
22.214.171.124. Italy market size and forecast
126.96.36.199. Spain market size and forecast
188.8.131.52. Rest of Europe market size and forecast
7.3.4. Europe Vitamin D Testing Sales Market by Vitamin Type
7.3.5. Europe Vitamin D Testing Sales Market by End User
7.3.6. Europe Vitamin D Testing Sales Market by Application
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
184.108.40.206. Japan market size and forecast
220.127.116.11. China market size and forecast
18.104.22.168. India market size and forecast
22.214.171.124. Rest of Asia-Pacific market size and forecast
7.4.4. Asia-Pacific Vitamin D Testing Sales Market by Vitamin Type
7.4.5. Asia-Pacific Vitamin D Testing Sales Market by End User
7.4.6. Asia-Pacific Vitamin D Testing Sales Market by Application
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
126.96.36.199. Latin America market size and forecast
188.8.131.52. Middle East market size and forecast
184.108.40.206. Africa market size and forecast
7.5.4. LAMEA Vitamin D Testing Sales Market by Vitamin Type
7.5.5. LAMEA Vitamin D Testing Sales Market by End User
7.5.6. LAMEA Vitamin D Testing Sales Market by Application
CHAPTER 8 COMPANY PROFILES
8.1. BIOMÉRIEUX INC
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. ABBOTT LABORATORIES INC.
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. SIEMENS HEALTHINEERS
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. F. HOFFMANN-LA ROCHE
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. DIASORIN S.P.A.
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. HOLOGIC, INC.
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. BIOKIT S.A.
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. THE VITAMIN D COMPANY
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. TOSOH BIOSCIENCE
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments